Review reports safety profiles of maternal pharmacotherapy during lactation, highlighting the need to balance infant drug exposure risks with maternal treatment benefits.
Due to its unique composition, breast milk is the ideal food for the baby, as it contains all the necessary nutrients. Breastfeeding is recommended by numerous scientific societies and is associated with many immediate as well as long-term benefits for mother and child. The use of pharmacotherapy in mothers during lactation raises concerns about the adverse consequences of treatment and the health of the child due to the distribution of drugs into breast milk. The following paper aims to present the safety profile of selected drug products during breastfeeding.
No takes yet. Share an insight, caveat, or question.
Czuba et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: